EX-10.4






 Exhibit 10.4 

CONFIDENTIAL 

FORM OF TRANSACTION SUPPORT AGREEMENT 

This TRANSACTION SUPPORT AGREEMENT (this “Agreement”) is entered into as
of                    , 2021, by and between BOA Acquisition Corp., a Delaware corporation (“BOA”), Selina Holding Company,
UK Societas (the “Company”), and Gomez Cayman SPV Limited, a Cayman Islands company (the “Shareholder”). Each of BOA, the Company and the Shareholder are sometimes referred to herein individually as a
“Party” and collectively as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Business Combination Agreement (defined below). 

RECITALS 
 WHEREAS,
it is intended that BOA, the Company and a subsidiary of the Company that is a Delaware corporation (“Merger Sub”), shall enter into a Business Combination Agreement. An advanced draft of the proposed Business Combination Agreement
is attached hereto as Exhibit B (such draft as amended, supplemented or otherwise modified from time to time (x) in accordance with this Agreement, and (y) (once entered into) in accordance with its terms and this Agreement,
the “Business Combination Agreement”), pursuant to which, among other things, Merger Sub will merge with and into BOA, with BOA as the surviving company in the merger and, as a result of such merger, among other things, all of the
issued and outstanding capital stock of BOA at the Effective Time shall be automatically converted into the right to receive Company Ordinary Shares, in each case, on the terms and subject to the conditions set forth in the Business Combination
Agreement; 
 WHEREAS, the Shareholder is the legal and beneficial owner of the number and class or series (as applicable) of Equity
Securities of the Company set forth on Schedule A hereto (together with any other Equity Securities of the Company that the Shareholder acquires legal or beneficial ownership of after the date hereof, collectively, the “Subject
Company Shares”); 
 WHEREAS, in consideration for the benefits to be received by the Shareholder under the terms of the
Business Combination Agreement and as a material inducement to BOA and the Company to enter into and consummate the transactions contemplated by the Business Combination Agreement, the Shareholder agrees to enter into this Agreement and to be bound
by the agreements, covenants and obligations contained in this Agreement; and 
 WHEREAS, the Parties acknowledge and agree that
neither BOA nor the Company would have entered into and agreed to consummate the transactions contemplated by the Business Combination Agreement without the Shareholder entering into this Agreement and agreeing to be bound by the agreements,
covenants and obligations contained in this Agreement. 













 NOW, THEREFORE, in consideration of the premises and the mutual promises set forth
herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows: 

AGREEMENT 

1. Company Shareholder Approval and Related Matters. 

(a) As promptly as reasonably practicable (and in any event within five (5) Business Days) following the date that the notice of the
Company’s general meeting is delivered by the Company, the Shareholder shall, and shall cause any other registered holder of the Subject Company Shares to, duly execute and deliver to the Company and BOA, the voting proxy in substantially the
form attached hereto as Exhibit A in respect of all the Subject Company Shares. In addition, prior to the Termination Date (as defined herein), the Shareholder irrevocably and unconditionally agrees that, at any meeting of the
shareholders of the Company (whether annual or special and whether or not an adjourned or postponed meeting, however called and including any adjournment or postponement thereof) and in connection with any written consent of shareholders of the
Company, the Shareholder shall, and shall cause any other registered holder of any of the Subject Company Shares to vote (in person or by proxy), or consent to any action by written consent or resolution with respect to, as applicable, the Subject
Company Shares, in favor of all of the matters, actions and proposals contemplated by the Company Shareholder Resolutions set forth on Exhibit A hereto. Without limiting the generality of the foregoing, prior to the earlier to occur of
the Closing and the Termination Date and subject to the other terms of this Agreement, (i) to the extent that it is necessary or advisable, for any matters, actions or proposals to be approved by the Shareholder in connection with, or otherwise
in furtherance of, the transactions contemplated by the Business Combination Agreement and/or the Ancillary Documents, the Shareholder shall vote (or cause to be voted) the Subject Company Shares in favor of and/or consent to any such matters,
actions or proposals promptly following written request thereof from the Company (in each case to the extent that such matters, actions or proposals are not adverse to the Shareholder), and (ii) the Shareholder shall vote (or cause to be voted)
the Subject Company Shares against and withhold consent with respect to (A) any Company Acquisition Proposal or (B) any other matter, action or proposal that would, to the Shareholder’s knowledge based on publicly available
information or as advised by the Company in writing, reasonably be expected to result in (x) a breach of any of the Company’s covenants, agreements or obligations under the Business Combination Agreement or (y) any of the conditions
to the Closing set forth in Sections 6.1 or 6.2 of the Business Combination Agreement not being satisfied; provided, however, that the Shareholder shall have no liability under this Section 1(a) for voting in favor of a proposal that the
Company has advised is not in violation of the Business Combination Agreement. 
 For the purposes of this Agreement, (i) “adverse to the
Shareholder” means (A) adverse to its rights or economic position (as a Company Shareholder) as contemplated by the Company Shareholders Agreement, this Agreement (including as provided in the Business Combination Agreement exhibited
hereto and the consent rights in Section 15), the Company Shareholders Agreement and the Investor Rights Agreement to which Shareholder becomes party, in each case, as amended, modified or supplemented from time to time in accordance
with the terms hereof or thereof (as applicable), and the resolutions included in the Company Shareholder Resolutions, or (B) imposing or increasing obligations of Shareholder other than as expressly contemplated by such agreement(s) as
presented on the date hereof and amended, modified or supplemented in accordance with this Agreement or (in the case of the Company Shareholders Agreement, in accordance with its terms, or by such resolutions; and (ii) “Investor Rights
Agreement” means the draft Investor Rights Agreement attached hereto as Exhibit C, as amended, supplemented or otherwise modified from time to time in accordance with (x) this Agreement (including to conform with
Section 2(g)) and, (y) (once entered into) its terms and this Agreement. 
 (b) Without limiting any other rights or
remedies of the Company, the Shareholder hereby irrevocably appoints the Company or any individual designated by the Company as the Shareholder’s agent, attorney-in-fact and proxy (with full power of substitution and resubstituting), for and in
the name, place and stead of the Shareholder, to attend on behalf of the Shareholder the general meeting or any meeting of the Company Shareholders with respect to the matters described in Section 1(a), to include the Subject Company
Shares in any computation for purposes of establishing a quorum at any such meeting of the Company Shareholders, to vote (or cause to be voted) the Subject Company Shares or consent (or withhold consent) with respect to any of the matters described
in Section 1(a) in connection with any meeting of the Company Shareholders or any action by written consent by the Company Shareholders (including the Company Shareholder Resolutions), in each case, in the event that (i) the
Shareholder fails to perform or otherwise comply with the covenants, agreements or obligations set forth in Section 1(a), (ii) any Proceeding is pending or threatened by or on behalf of the Shareholder that challenges or could
impair the enforceability or validation of the covenants, agreements or obligations set forth in this Agreement or (iii) BOA and/or the Company notifies the Shareholder of its intent to exercise the proxy set forth in this
Section 1(b). For the avoidance of doubt, this does not prevent Shareholder from withdrawing or otherwise challenging the voting proxy if this Agreement has terminated in accordance with its terms. 

 

  
 2 














 (c) The proxy granted by the Shareholder pursuant to Section 1(b) is
coupled with an interest sufficient in law to support an irrevocable proxy and is granted in consideration for BOA and the Company entering into the Business Combination Agreement and agreeing to consummate the transactions contemplated thereby. The
proxy granted by the Shareholder pursuant to Section 1(b) is also a durable proxy and shall survive the bankruptcy, dissolution, death, incapacity or other inability to act by the Shareholder and shall revoke any and all prior
proxies granted by the Shareholder with respect to the Subject Company Shares. The vote or consent of the proxyholder with respect to the matters described in Section 1(a) shall control in the event of any conflict between such vote
or consent by the proxyholder of the Subject Company Shares and a vote or consent by the Shareholder of the Subject Company Shares (or any other Person with the power to vote or provide consent with respect to the Subject Company Shares) with
respect to the matters described in Section 1(a). The proxyholder may not exercise the proxy granted pursuant to Section 1(b) on any matter except for those matters described in Section 1(a). For the
avoidance of doubt, the proxy granted pursuant to Section 1(b) shall terminate automatically with no further action required if this Agreement is terminated in accordance with its terms. 

(d) The Company and BOA acknowledge and agree that the Company general meeting contemplated by Section 1(a) (or the
solicitation of written consents of the shareholders of the Company) shall be held (or sought) within thirty days after the date of the Business Combination Agreement and otherwise in accordance with Section 5.9(b) of the Business
Combination Agreement. Without limiting the generality of the foregoing, the proxy contemplated by Section 1(b) shall not be effective for any general meeting of the Company’s shareholders not in compliance with this
Section 1(d). 
 (e) The Company and BOA acknowledge and agree that the voting proxy contemplated by this
Section 1 shall not supersede or limit any rights of the Shareholder, including the consent rights contemplated by this Agreement save, for the avoidance of doubt, that the Shareholder may not exercise any such rights to take or omit to
take any action the taking or omission of which by it is contrary to the express terms of this Agreement. 
 2. Other Covenants and
Agreements. 
 (a) [Intentionally deleted.] 

(b) The Shareholder shall solely be bound by and subject to (i) Sections 5.3(a) (Confidentiality) and 5.4(a) (Public
Announcements) of the Business Combination Agreement to the same extent as such provisions apply to the parties to the Business Combination Agreement, as if the Shareholder is directly party thereto, and (ii) the first sentence of
Section 5.6(a) (Exclusive Dealing) and Section 8.18 (Trust Account Waiver) of the Business Combination Agreement to the same extent as such provisions apply to the Company, as if the Shareholder is directly party thereto. The
Shareholder shall not be subject to or bound by any other provision of the Business Combination Agreement and shall have no responsibility for any breach or violation of or failure to comply with the provisions of the Business Combination Agreement
by any other Person. 
 (c) The Shareholder hereby agrees to promptly execute and deliver (including upon any written request from the
Company) any and all additional agreements, documents or instruments, take, or cause to be taken, all actions and provide, or cause to be provided, all additional information or other materials as may be necessary or advisable, in connection with,
or otherwise in furtherance of, the consummation of the transactions contemplated by the Business Combination Agreement or this Agreement (in each case to the extent that such agreements, documents or instruments are not adverse to the Shareholder).


  
 3 














 (d) The Shareholder acknowledges and agrees that BOA and the Company is entering into
the Business Combination Agreement in reliance upon the Shareholder entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the agreements, covenants and obligations contained in this
Agreement, and but for the Shareholder entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the agreements, covenants and obligations contained in this Agreement, neither BOA nor the Company
would not have entered into or agreed to consummate the transactions contemplated by the Business Combination Agreement. 
 (e) BOA and
the Company acknowledge and agree that the Shareholder is entering into this Agreement in reliance upon BOA and the Company entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the
agreements, covenants and obligations contained in this Agreement, and but for BOA and the Company entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with, as applicable, the agreements, covenants and
obligations contained in this Agreement, the Shareholder would not have entered into or agreed to consummate the transactions contemplated by this Agreement; 

(f) The Company shall provide to the Shareholder a copy of the Business Combination Agreement, the Investor Rights Agreement, the Sponsor
Letter Agreement, the PIPE Subscription Agreements, the Transaction Support Agreements and the Amended and Restated Warrant Agreement (and each amendment agreement thereto) (whether or not the Shareholder is a party) as soon as reasonably practical
after the earlier of the Company entering into the same or agreeing to a final form with BOA. 
 (g) BOA and the Company acknowledge
and agree that, pursuant to the Investor Rights Agreement to be entered into with the Shareholder (amongst others) prior to the Effective Time, the Shareholder shall: 

(i) be subject to customary lock-up terms with respect to its Company Ordinary Shares including a post-Effective Time
lock-up period not to exceed 12 months, subject to the exceptions from lock-up provided to Company Shareholders generally pursuant to the Investor Rights Agreement; and 

(ii) receive registration rights not less favourable than those afforded to any other Company Shareholder that is party to
the Investor Rights Agreement; and 
 in each case on terms to be further set out in the Investor Rights Agreement that are consistent with the foregoing.

 (h) The Company and BOA acknowledge and agree that Shareholder will have no support obligations in respect of the board of the
Company (or elections thereto) following the Effective Time. 
 (i) The Company agrees that, on the Effective Time and until the date
on which the Shareholder has, directly or indirectly, has transferred or otherwise disposed of such number of Company Ordinary Shares which amount to two-thirds of the number of Company Ordinary Shares it holds as of the Effective Time, the Company
shall expressly grant the Shareholder with the right to appoint an individual to attend any board of director meeting of the Company (the “Observer”) as an observer, subject to having the Observer sign a confidentiality agreement with the
Company on customary terms (which terms shall include, for the avoidance of doubt, restrictions on insider trading). Shareholder may exercise its rights under this Section 2(i) unilaterally and any failure by the Shareholder to appoint the
Observer or replace such Observer which has been previously removed by the Shareholder, shall not be deemed as a waiver to Shareholder’s right to appoint an Observer. 

  
 4 














 (j) [Intentionally deleted]. 

3. Shareholder Warranties. The Shareholder warrants to BOA and the Company as follows: 

(a) If the Shareholder is an entity, such Shareholder is a corporation, limited liability company or other applicable business entity duly
organized or formed, as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case, with respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) under the
Laws of its jurisdiction of formation or organization (as applicable). 
 (b) If the Shareholder is an entity, such Shareholder
(i) has the requisite corporate, limited liability company or other similar power and authority to execute and deliver this Agreement, to perform his, her or its covenants, agreements and obligations hereunder (including, for the avoidance of
doubt, those covenants, agreements and obligations hereunder that relate to the provisions of the Business Combination Agreement), and to consummate the transactions contemplated hereby, and (ii) the execution and delivery of this Agreement has
been duly authorized by all necessary corporate (or other similar) action on the part of the Shareholder. This Agreement has been duly and validly executed and delivered by the Shareholder and constitutes a valid, legal and binding agreement of the
Shareholder (assuming that this Agreement is duly authorized, executed and delivered by BOA and the Company) enforceable against the Shareholder in accordance with its terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium
or other Laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity). 
 (c) No
consent, approval or authorization of, or designation, declaration or filing with, any Governmental Entity is required on the part of the Shareholder with respect to the Shareholder’s execution, delivery or performance of his, her or its
covenants, agreements or obligations under this Agreement (including, for the avoidance of doubt, those covenants, agreements and obligations under this Agreement that relate to the provisions of the Business Combination Agreement) or the
consummation of the transactions contemplated hereby, except for any consents, approvals, authorizations, designations, declarations, waivers or filings, the absence of which would not adversely affect the ability of the Shareholder to perform, or
otherwise comply with, any of his, her or its covenants, agreements or obligations hereunder in any material respect. 
 (d) None of
the execution or delivery of this Agreement by the Shareholder, the performance by the Shareholder of any of his, her or its covenants, agreements or obligations under this Agreement (including, for the avoidance of doubt, those covenants,
agreements and obligations under this Agreement that relate to the provisions of the Business Combination Agreement) or the consummation of the transactions contemplated hereby will, directly or indirectly (with or without due notice or lapse of
time or both) (i) if the Shareholder is an entity, result in any breach of any provision of the Shareholder’s Governing Documents, (ii) result in a violation or breach of, or constitute a default or give rise to any right of
termination, Consent, cancellation, amendment, modification, suspension, revocation or acceleration under, any of the terms, conditions or provisions of any Contract to which the Shareholder is a party, (iii) violate, or constitute a breach
under, any Order or applicable Law to which the Shareholder or any of his, her or its properties or assets are bound or (iv) result in the creation of any Lien upon the Subject Company Shares, except, in the case of any of
clauses (ii) and (iii) above, as would not adversely affect the ability of the Shareholder to perform, or otherwise comply with, any of his, her or its covenants, agreements or obligations hereunder in any material
respect. 

  
 5 














 (e) The Shareholder is the registered legal and beneficial owner of the Subject Company
Shares and has valid, good and marketable title to the Subject Company Shares, free and clear of all Liens other than Liens arising by operation of securities laws and any other Liens that would not adversely affect the ability of the Shareholder to
perform, or otherwise comply with, any of his, her or its covenants, agreements or obligations hereunder in any material respect. Except for the Equity Securities of the Company set forth on Schedule A hereto, together with any other Equity
Securities of the Company that the Shareholder acquires legal or beneficial ownership of after the date hereof, the Shareholder does not own, legally or beneficially, any Equity Securities of any Group Company or have the right to acquire any Equity
Securities of any Group Company. The Shareholder has the sole right to vote (and provide consent in respect of, as applicable) the Subject Company Shares and, except for this Agreement, the Business Combination Agreement and the Company Shareholders
Agreement, the Shareholder is not party to or bound by (i) any option, warrant, purchase right, or other Contract that could (either alone or in connection with one or more events, developments or events (including the satisfaction or waiver of
any conditions precedent)) require the Shareholder to Transfer any of the Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of any of the Subject Company Shares. 

(f) There is no Proceeding pending or, to the Shareholder’s knowledge, threatened against or involving the Shareholder or any of
his, her or its Affiliates that, if adversely decided or resolved, would reasonably be expected to adversely affect the ability of the Shareholder to perform, or otherwise comply with, any of its covenants, agreements or obligations under this
Agreement in any material respect. 
 (g) The Shareholder, on his, her or its own behalf and on behalf of his, her or its
Representatives, acknowledges, warrants and agrees that (i) he, she or it has conducted his, her or its own independent review and analysis of, and, based thereon, has formed an independent judgment concerning, the business, assets, condition,
operations and prospects of, BOA, the Company and the transactions contemplated by this Agreement, the Business Combination Agreement and the other Ancillary Documents and (ii) he, she or it has been furnished with or given access to such
documents and information about BOA, the Company and their respective businesses and operations as he, she or it and his, her or its Representatives have deemed necessary to enable him, her or it to make an informed decision with respect to the
execution, delivery and performance of this Agreement or the other Ancillary Documents to which he, she or it is or will be a party and the transactions contemplated hereby and thereby. 

(h) The Shareholder is not insolvent or unable to pay its debts within the meaning of the Insolvency Act 1986 or any other applicable
insolvency legislation. Nor has any step been taken in any applicable jurisdiction to initiate any process by or under which: 

(i) the ability of the creditors of the Shareholder to take any action to enforce their debts is suspended, restricted or
prevented, including (without limitation) pursuant to a moratorium under Part A1 of the Insolvency Act 1986; 

(ii) one or all of the creditors of the Shareholder accept, by agreement or in pursuance of a court order, an amount less
than the sums owing to them in satisfaction of those sums, or make any other compromise or arrangement with the Shareholder (including, without limitation a restructuring plan under Part 26A of the Companies Act 2006), with a view to preventing
the dissolution of the Shareholder; or 
 (iii) a person is appointed to manage the affairs, business and assets of the
Shareholder on behalf of its creditors. 

  
 6 














 (i) In entering into this Agreement and the other Ancillary Documents to which he, she
or it is or will be a party, the Shareholder has relied solely on his, her or its own investigation and analysis and the representations and warranties expressly set forth in the Ancillary Documents to which he, she or it is or will be a party and
no other representations or warranties of BOA or the Company or any other Person, either express or implied, and the Shareholder, on his, her or its own behalf and on behalf of his, her or its Representatives, acknowledges, represents, warrants and
agrees that, except for the representations and warranties expressly set forth in this Agreement, the Business Combination Agreement (but recognizing and acknowledging that the representations and warranties in the Business Combination Agreement may
be amended, modified or supplemented in accordance with this Agreement prior to the date that agreement is entered into by its parties) or in the other Ancillary Documents to which he, she or it is or will be a party, none of BOA, the Company or any
other Person makes or has made any representation or warranty, either express or implied, in connection with or related to this Agreement, the Business Combination Agreement or the other Ancillary Documents or the transactions contemplated hereby or
thereby. 
 4. Transfer of Subject Securities. Except as expressly contemplated by the Business Combination Agreement or with
the prior written consent of BOA and the Company (such consent to be given or withheld in those Parties’ sole discretion), from and after the date hereof until the earlier of the (i) Closing of the Business Combination Agreement or
(ii) the termination of the Business Combination Agreement (the “Termination Date”), the Shareholder agrees not to (a) Transfer any of the Subject Company Shares, other than Transfers among Affiliates of the Shareholder in
accordance with the terms of the Company Shareholders Agreement (provided any transferee Affiliate executes a joinder agreeing to be bound by the terms of this Agreement prior to the Transfer being completed), (b) enter into (i) any
option, warrant, purchase right, or other Contract that could (either alone or in connection with one or more events, developments or events (including the satisfaction or waiver of any conditions precedent)) require the Shareholder to Transfer the
Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of the Subject Company Shares, or (c) take any actions in furtherance of any of the matters described in the foregoing
clauses (a) or (b). For purposes of this Agreement, “Transfer” means any, direct or indirect, sale, transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest in or disposition
or encumbrance of an interest (whether with or without consideration, whether voluntarily or involuntarily or by operation of law or otherwise). 

5. Termination. This Agreement shall automatically terminate, without any notice or other action by any Party, upon the earlier of
(a) the Effective Time and (b) the termination of the Business Combination Agreement in accordance with its terms. Upon termination of this Agreement as provided in the immediately preceding sentence, none of the Parties shall have any
further obligations or Liabilities under, or with respect to, this Agreement. Notwithstanding the foregoing or anything to the contrary in this Agreement, (i) the termination of this Agreement pursuant to Section 5 shall not affect
any Liability on the part of any Party for a material breach of any covenant or agreement set forth in this Agreement prior to such termination or actual fraud, (ii) Section 2(b)(i) (solely to the extent that it relates to
Section 5.3(a) (Confidentiality) of the Business Combination Agreement) and the warranties set forth in Sections 3(g) and (h) shall each survive any termination of this Agreement,
(iii) Section 2(b)(i) (solely to the extent that it relates to Section 5.4(a) (Public Announcements) of the Business Combination Agreement) shall survive the termination of this Agreement pursuant to
Section 5(a), (iv), Section 2(b)(ii) (solely to the extent that it relates to Section 8.18 (Trust Account Waiver) of the Business Combination Agreement) shall survive the termination of this Agreement pursuant to
Section 5(b), and (v) Section 2(h) shall survive the termination of this Agreement pursuant to Section 5(a). 

In addition, the Shareholder’s obligations pursuant to this Agreement (together with the proxies contemplated hereby) shall automatically terminate,
without any notice or other action by any Party, upon the earlier of (x) such time as either BOA or the Company violate their respective obligations to the Shareholder under this Agreement, (y) the Business Combination Agreement (or any
provision of thereof) or any Ancillary Agreement (or any provision of thereof) is amended, supplemented, modified or waived in any manner adverse to the Shareholder without the prior written consent of the Shareholder (such consent not to be
unreasonably withheld or delayed), (z) June 30, 2022, and (aa) if the signing of the Business Combination Agreement with BOA by the Company and BOA is not publicly announced on or before 15 December 2021. 

  
 7 














 6. No Recourse. This Agreement may only be enforced against, and any action for
breach of this Agreement may only be made against, the Parties, and without limiting the generality of the foregoing, none of the Representatives of any of BOA, the Company or the Shareholder shall have any Liability arising out of or relating to
this Agreement or the transactions contemplated hereby, including with respect to any claim (whether in tort, contract or otherwise) for breach of this Agreement or in respect of any written or oral warranties made or alleged to be made in
connection herewith, except as expressly provided herein. 
 7. Notices. All notices, requests, claims, demands and other
communications hereunder shall be in writing and shall be given (and shall be deemed to have been duly given) by delivery in person, by e-mail (having obtained electronic delivery confirmation thereof (i.e., an electronic record of the sender that
the email was sent to the intended recipient thereof without an “error” or similar message that such email was not received by such intended recipient)), or by registered or certified mail (postage prepaid, return receipt requested) (upon
receipt thereof) to the other Parties as follows: 
 If to BOA, to: 

BOA Acquisition Corporation 

2600 Virginia Ave NW, 
 Suite
T23 Management Office 
 Washington, D.C. 20037 

Attention:     Ben Friedman, CFO 

E-mail:         ben@friedmancap.com 

with a copy (which shall not constitute notice) to: 

King & Spalding LLP 

1700 Pennsylvania Avenue NW 

Washington, DC 20006 

Attention:     Brian E. Ashin Alan M. Noskow 

E-mail:         bashin@kslaw.com anoskow@kslaw.com 

If to the Company, to: 
 Selina
Holding Company, UK Societas 
 6th Floor, 2 London Wall Place 

Barbican, London EC2Y 5AU 

Attention:     Jon Grech, General Counsel 

E-mail:         jon.grech@selina.com 

with a copy (which shall not constitute notice) to: 

Morgan Lewis & Bockius UK LLP 

Condor House, 5-10 St Paul’s Churchyard 

London EC4M 8AL 
 Attention:
    Tomasz Wozniak 
 E-mail:         tomasz.wozniak@morganlewis.com 

  
 8 














 If to the Shareholder, to: 

Colony LatAm Partners 
 Pedregal
24, 8th Floor—801B, 
 Colonia Lomas de Virreyes 

CDMX, México. 11020 

Attention:     Eduardo Cortina 

    Miguel Mestre 

Email: ecortina@clny.com 

mmestre@clny.com 
 with a
copy (which shall not constitute notice) to: 
 Baker McKenzie 

Pedregal 24, 8th Floor—801B, 

Colonia Lomas de Virreyes 

CDMX, México. 11020 

Attention:     Lorenzo Ruiz de Velasco 

Email:         lorenzo.ruizdevelasco@bakermckenzie.com 

or to such other address as the Party to whom notice is given may have previously furnished to the others in writing in the manner set forth above. 

8. Entire Agreement. This Agreement, the Business Combination Agreement and documents referred to herein and therein constitute
the entire agreement of the Parties with respect to the subject matter of this Agreement, and supersede all prior agreements and undertakings, both written and oral, among the Parties with respect to the subject matter of this Agreement, except as
otherwise expressly provided in this Agreement. 
 9. Amendments and Waivers; Assignment Any provision of this Agreement may be
(a) amended if, and only if, such amendment is in writing and signed by the Shareholder, the Company and BOA and (b) waived if, and only if, such waiver is in writing and signed by the Party against whom such waiver is to be effective.
Notwithstanding the foregoing, no failure or delay by any Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder.
Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assignable by the Shareholder without the prior written consent of BOA and the Company (to be withheld or given in their sole discretion). Any attempted
assignment of this Agreement not in accordance with the terms of this Section 11 shall be void. 
 10. Fees and
Expenses. Except, in the case of BOA, as otherwise set forth in the Business Combination Agreement, all fees and expenses incurred in connection with this Agreement and the transactions contemplated hereby, including the fees and disbursements
of counsel, financial advisors and accountants, shall be paid by the Party incurring such fees or expenses. 

  
 9 














 11. Remedies. Except as otherwise expressly provided herein, any and all
remedies provided herein will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy.
The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that either Party does not perform his, her or its respective obligations under the provisions of this
Agreement in accordance with their specific terms or otherwise breach such provisions. It is accordingly agreed that each Party shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches of
this Agreement and to enforce specifically the terms and provisions of this Agreement, in each case, without posting a bond or undertaking and without proof of damages and this being in addition to any other remedy to which they are entitled at law
or in equity. Each Party agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an
adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. 
 12. No
Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties and their respective successors and permitted assigns and is not intended, nor shall be construed, to give any Person, other than the Parties and their
respective successors and assigns, any legal or equitable right, benefit or remedy of any nature whatsoever by reason this Agreement. Nothing in this Agreement, expressed or implied, is intended to or shall constitute the Parties, partners or
participants in a joint venture. 
 13. Miscellaneous. Sections 8.1 (Non-Survival), 8.5 (Governing Law)], 8.7 (Construction;
Interpretation), 8.10 (Severability), 8.11 (Counterparts; Electronic Signatures), 8.15 (Waiver of Jury Trial) and 8.16 (Submission to Jurisdiction) of the Business Combination Agreement are incorporated herein by reference and shall apply to this
Agreement, mutatis mutandis. 
 14. Interim Notice. Neither the Company nor BOA shall, directly or indirectly, do any of
the following without the prior written notice to Shareholder at least one Business Days prior to taking action (or in the case of entering into the Business Combination Agreement, such other period as may be specified in the notice of the general
meeting referred to in Section 5.9(b) of the Business Combination Agreement): (i) entering into the Business Combination Agreement or any Ancillary Agreement, or (ii) amending, supplementing, modifying, waiving, granting any
consent or making any election or determination that is material in the context of the Business Combination Agreement or such Ancillary Agreement (as applicable). 

15. Interim Consent Rights. Neither the Company nor BOA shall, directly or indirectly, do any of the following without the prior
written consent of Shareholder: 
 (a) amending, supplementing, modifying, waiving, granting any consent or making any election or
determination under any provision of, the Business Combination Agreement or any Ancillary Agreement adverse to the Shareholder; provided that the Shareholder shall not unreasonably withhold or delay its consent to such action; 

(b) agreeing (pursuant to the Business Combination Agreement, any Ancillary Agreement or otherwise) to (i) a (pre-money) value of
less than $800,000,000 (eight hundred million US dollars) for the equity of the Company for purposes relating to the business combination contemplated by the Business Combination Agreement or (ii) a cash condition (as described in
Section 6.3(f) of the Business Combination Agreement attached hereto) of less than $70 million; 
 (c) permitting the Company
to have a governance structure immediately after the Effective Time other than consistent with the following: 

(i) seven Company directors, of which seven: 

(A) the Founders shall be two directors; and 

  
 10 














 (B) each other director shall be an “independent director”
in accordance with the criteria for independence established by Rule 10A-3 under the Securities Exchange Act of 1934, as amended and the rules of the NYSE applicable to members of the audit committee (the “Independent
Directors”), regardless of who nominates such Independent Directors, of which; 
 (1) BOA shall nominate
two of Jeff Citrin, Steve Rudnitsky, Jenny Abramson, Noam Bardin, Anthony Wanger and David Glazer to be Independent Directors; 

(2) Shareholder shall nominate one Independent Director; 

(3) 166 2nd LLC (as defined in the Company Shareholders Agreement)
shall nominate one Independent Director; and 
 (4) Company Shareholder(s) other than Dekel Development Holding,
S.A., Shareholder, the Colony Investors, the Additional Series C Investor and the Designated Additional Series C Investor shall nominate the remaining Independent Director; and 

(ii) if notified to the Company prior to BOA and the Company entering into the Business Combination Agreement, the
respective nominees shall be named in the Business Combination Agreement; 
 (d) in respect of the PIPE Financing: 

(ii) entering into or consummating a PIPE Financing that provides for (or otherwise amending, modifying, supplements or
waiving the terms of a PIPE Financing the result of which would provide for): 
 (A) the Company to receive (or be
deemed to receive), directly or indirectly (including through the merger involving BOA), whether prior to, on or shortly following the Effective Time (or otherwise in connection with the transactions contemplated by the Business Combination
Agreement) aggregate cash proceeds from PIPE Investors of less than $70,000,000 or of more than $150,000,000; or 

(B) the Company to receive (or be deemed to receive), directly or indirectly (including through the merger involving
BOA), whether prior to or on the Effective Time aggregate cash proceeds from issuing Company Ordinary Shares to PIPE Investors (the “Equity PIPE”) of less than $40,000,000; or 

(C) Company Ordinary Shares to be issued in the Equity PIPE for less than $10 per Company Ordinary Share; or 

(D) the Company to receive (or be deemed to receive), whether prior to or on the Effective Time aggregate cash proceeds
from the issue of convertible loan note instruments to PIPE Investors (“Convertible PIPE Instruments”) more than twice the aggregate proceeds to be received (or deemed to be received) by the Company from the Equity PIPE; or


  
 11 














 (E) in respect of Convertible PIPE Instruments: 

(1) the term of the loan note (absent conversion or redemption) is less than four years from the date on which the
convertible loan note instrument is entered into; or 
 (2) the interest rate for PIK interest is greater than
8.5% per annum; or 
 (3) the interest rate for interest payable only in cash is greater than 6.5% per annum;
or 
 (4) (other than pursuant to a re-set provision consistent with the immediately following clause (5)) the
price per share at which Convertible PIPE Instruments convert into Company Ordinary Shares (a “Conversion Price”) is less than $10.50; or 

(5) providing for a re-set of the Conversion Price earlier than two years after the date on which the convertible loan
note instrument is entered into, or a post-reset Conversion Price of less than $8; or 
 (iii) entering into or
consummating a PIPE Financing other than on arm’s length commercial terms; 
 (e) taking any action to consummate the transactions
contemplated by the Business Combination Agreement if the PIPE Financing is less than $70 million (including waiving condition described in Section 6.3(f) of the advance draft of the Business Combination Agreement attached hereto other
than in accordance with this Agreement); 
 (f) taking any action to consummate the transactions contemplated by the Business
Combination Agreement if the terms of the transaction are not consistent with the terms contemplated by this Agreement (including waiving condition described in Section 6.3(f) of the advance draft of the Business Combination Agreement
attached hereto other than in accordance with this Agreement). 
 For the avoidance of doubt, for purposes of this Agreement prior written consent of the
Shareholder may be given pursuant to this Agreement or (if Shareholder is party to such other agreement referred to herein) such agreement (as applicable), including by way of Shareholder entering into an agreement to effect such amendment,
supplementation, modification or waiver. 
 [Signature page follows] 

 

  
 12 














 IN WITNESS WHEREOF, the Parties have executed and delivered this Transaction Support Agreement as of the
date first above written. 
  

			
	 BOA ACQUISITION CORP.

		
	By:	 	/s/ Brian Friedman
	Name:	 	Brian Friedman
	Title:	 	Authorized Member


 [Signature Page to Transaction Support Agreement] 













 
			
	 SELINA HOLDING COMPANY, UK SOCIETAS

		
	By:	 	/s/ Rafael Museri
	 Name:
	 	 Rafael Museri

	 Title:
	 	 Director



 [Signature Page to Transaction Support Agreement] 

 













 
			
	 GOMEZ CAYMAN SPV LIMITED

		
	By:	 	/s/ Donna Hansen
	Name:	 	Donna Hansen
	Title:	 	Vice President


 [Signature Page to Transaction Support Agreement] 













 SCHEDULE A 

 

					
	 Class/Series Securities
	  	Number of Shares	 
	 Company Series A Shares
	  	 	95,374	 
	 Company Series B Shares
	  	 	1,577,391	 
	 Company Series C Shares
	  	 	47,680	 
	 Company Series D Shares
	  	 	—  	 
	 Company Ordinary Shares
	  	 	—  	 
	 Other Company Equity Securities
	  	 	—  	 














 SCHEDULE B 

[Intentionally deleted.] 













 EXHIBIT A 

Proxy 
 The form of proxy attached
to the Circular containing Notice of Meetings dated 16 August 2021, with such amendments as are required to give effect to the terms of this Agreement. 













 EXHIBIT B 

Draft Business Combination Agreement 













 EXHIBIT C 

Draft Investor Rights Agreement